Intelligo

Norwegian-registered foreign company · Nordre Follo

MEDELA MEDICAL NORGE NUF

ActiveWholesale of pharmaceutical and medical goods (46.460)

Chief executive
Milan Lexèn
Business address
Rosenholmveien 25, 1414 Trollåsen

The website has not been read for a card yet.

The life line 2025–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2025: NOK 37.0m.

  1. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 5 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

MEDELA MEDICAL NORGE NUF is a norwegian-registered foreign company in Nordre Follo, in the industry wholesale of pharmaceutical and medical goods. The chief executive is Milan Lexèn. In 2025 the company had NOK 37.0m in operating revenue and a net profit of NOK 3.0m.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 10 Nov 2026

  • Endring av signatur
  • Annual accounts filed 2024 → 2025
  • Won a tender from SYKEHUSINNKJØP HF
  • Godkjente årsregnskap

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

None registered

None of the rules apply.The rules are fixed: bankruptcy, missing annual accounts, three years of losses, negative equity and the like. Checked 15 Nov 2026.

Overview

§ 03 Key figures

Revenue NOK 37.0m in 2025

Revenue

NOK 37.0m

— from 2024

20232025

Operating profit

NOK 2.9m

— from 2024

20232025

Net profit

NOK 3.0m

— from 2024

20232025

Equity

—

— from 2024

20232025

Source: the Register of Company Accounts, read 5 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2025

Of every krone of operating revenue in 2025:

  • Operating costs 92%
  • Left as operating result 8%

Source: the Register of Company Accounts, read 5 Nov 2026

Finances

§ 05 Financial health

Financial year 2025

RevenueNOK 37.0m Operating margin7.8%
  • MEDELA MEDICAL NORGE NUF, 2025
  • Industry median, assumed: NOK 8.5m · 4.3%

Source: the Register of Company Accounts, read 5 Nov 2026. The median is derived by Intelligo from 538 companies in 46.460 Wholesale of pharmaceutical and medical goods, not stated by the source.

Finances

§ 06 Accounts

1 years, latest 2025

NOK 1,0002025
Operating revenue36,969
Operating profit2,884
Profit before tax2,990
Net profit2,990
Total assets12,899
Equity—
Liabilities12,899

Source: the Register of Company Accounts, read 5 Nov 2026 · All 1 years →

Management and ownership

§ 07 Officers

4 officers now

Source: the Brønnøysund Register Centre, read 11 Nov 2026 · All 4 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

None registered

No signature or procuration registered.The Register of Business Enterprises has no provision for the company. Checked 15 Nov 2026.

Management and ownership

§ 09 Owners

None registered

No owners registered.The Tax Administration's shareholder register covers limited companies and has no owners for this business. Checked 15 Nov 2026.

Management and ownership

§ 10 Group

None registered

Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.

Management and ownership

§ 11 Portfolio

None registered

No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

Management and ownership

§ 12 Network

None registered

No connections.Nobody with a role here has roles in other companies. Checked 15 Nov 2026.

Events and registers

§ 13 Events

6 since 2024

Events per year

20242026

  • Notices3
  • Tenders won2
  • Register changes1

Since 2024: 3 announcements, 1 register change and 2 tenders won. Most happened in 2024 and 2026.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 18 Nov 2026. Register changes are Intelligo's own observations. · All 6 events →

Events and registers

§ 14 Notices

4, latest 10 Nov 2026

  • Signatur
  • Godkjente årsregnskap
  • Godkjente årsregnskap

Source: The Brønnøysund Register Centre's announcements ↗, read 18 Nov 2026 · All 4 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 3 Nov 2010
  • VATRegistered
  • The Register of Business EnterprisesRegistered 3 Nov 2010
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

2 tenders

  • 2024
  • 2026
  • Won
  • Lost

Source: Doffin and TED, read 10 Jul 2026. · All 2 tenders →

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 46.460

Value awarded in Doffin and TED since 2023, among the companies MEDELA MEDICAL NORGE NUF has met in tenders:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

4 questions

  • Who is the chief executive of MEDELA MEDICAL NORGE NUF?
    Milan Lexèn. § 07
  • What was the revenue in 2025?
    NOK 37.0m in the company. § 06
  • Who is the auditor?
    ERNST & YOUNG AS. § 07
  • Where is MEDELA MEDICAL NORGE NUF based?
    Rosenholmveien 25, 1414 Trollåsen.

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose